XTalks

JUNE 14, 2024

Ontario, Canada’s largest province by population, is stepping up its commitment to the life sciences sector with an investment of $40 million. The $40 million will come from the Venture Ontario Fund, which is dedicated to helping Ontario life sciences companies and biomanufacturers innovate, grow and compete in global markets.

Life Science 52

Life Science Insulin Manufacturing Research 52

Delveinsight

JULY 21, 2021

However, some of the key pharma companies at the global level have shifted their focus towards these diverse diseases. Through this article, we have covered the major autoimmune diseases and the key companies striving to transform the treatment landscape of the respective disease. It is also known as insulin-dependent diabetes.

Pharma Companies 94

Pharma Companies Marketing Insulin Development 94

Pharmaceutical Technology

JANUARY 31, 2023

Inflation Reduction Act Speaking during the keynote panel “FDA & ARPA-H: Life Sciences, Biopharma & Medtech Priorities in a New Year”, Califf discussed the Inflation Reduction Act of August 2022, which aims to lower prescription drug prices. That leaves three years for pharma companies to prepare. It’s a hot area.”

Drugs 130

Drugs Regulation Gene Therapy Insulin 130

XTalks

JANUARY 5, 2024

Eli Lilly launched LillyDirect this week, an online service that provides access to the company’s medicines, including its newly approved weight loss drug Zepbound (tirzepatide). Ricks, Lilly’s chair and CEO, in the company’s announcement. Zepbound was approved by the US Food and Drug Administration (FDA) in November 2023.

Drugs 59

Drugs Pharmacy Cosmetics Medicine 59

XTalks

FEBRUARY 14, 2024

Allocation of Profits, PBMs Under Fire The CEOs defended high prescription drug prices saying that a big chunk of pharma profits go towards funding the research and development of new medicines. Murphy interrogated this claim and specifically questioned the way companies allocate revenue.

Drugs 52

Drugs Insulin Pharmacy Development 52

XTalks

AUGUST 17, 2020

Suri, as the company’s approach is “a very unique marriage between very rational protein engineering and immunology.”. In the program, it was demonstrated that pro-insulin specific T cells from human subjects, which are prominent in patients with type 1 diabetes, could be effectively dampened with an Immuno-STAT.

Protein 98

Protein Engineer Immune Response In-Vivo 98